WHA74: KEI’s statement on expanding access to effective treatments for cancer and rare and orphan diseases including cell and gene-based therapies

At the World Health Organization’s 74th World Health Assembly, Knowledge Ecology International delivered the following remarks on expanding access to effective treatments for cancer and rare and orphan diseases including cell and gene-based therapies on Thursday, 27 May 2021. Non-state… Continue Reading

People’s Vaccine Alliance Letter to Prime Minister Trudeau Urgently Requesting the Amendment of Schedule 1

On May 18th, the People’s Vaccine Alliance sent Justin Trudeau, Prime Minister of Canada, a letter urgently requesting that vaccines, therapeutics and diagnostics for COVID-19 be added to Schedule 1 of the Patent Act. Below is the text of the PVA… Continue Reading

Texas A&M Vaccine Manufacturing Contract Shows that cGMP Manufacturing of COVID-19 Vaccines Can Start in Five Months 

A $265 million COVID-19 vaccine manufacturing contract between the Department of Health and Human Services (HHS) and the Texas A&M University System (TAMUS) to manufacture the Novavax and other COVID-19 vaccines demonstrates that a manufacturing facility can be retrofitted to… Continue Reading

KEI submission to Canada Standing Committee on International Trade and Investment Policy: Concerning COVID-19

Brief to Standing Committee on International Trade and Investment Policy: Selected Consideration Concerning COVID-19 Vaccines Knowledge Ecology International James Love and Arianna Schouten 30 April 2021 This brief will discuss (1) the scope and purpose of the proposed World Trade… Continue Reading